MassDevice7d
FDA clears revision knee implant from Zimmer Biomet
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.
Becker's Spine Review1d
Zimmer Biomet plans 3 more Rosa robotic indications
Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...
Hosted on MSN2mon
Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance
a component of its total knee implant system. "Zimmer Biomet’s total shoulder replacement system gains FDA 510(k) clearance" was originally created and published by Medical Device Network ...
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion™ Femur, a ...
Morningstar5d
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona® Revision SoluTion™ Femur, and Debut of ...
Morningstar8d
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
Knees at Zimmer Biomet. "We are proud to offer a total revision knee construct with no deliberate addition of the most common metal allergens (Nickel, Cobalt, & Chromium). Metal sensitivity is one ...
Zimmer Biomet Holdings, Inc.: Zimmer Biomet Receives FDA Clearance for Persona Revision SoluTion Femur
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ...